ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,179.68
-0.55%
Dow Jones
39,164.06
0.09%
Gold vs US Dollar
2,327.37
1.26%
Brent Oil
85.415
1.12%
Bitcoin
61,558.82
1.23%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. NeuroBo Pharmaceuticals Inc (NRBO) Share Price

NRBO NeuroBo Pharmaceuticals Inc

4.78
-0.05 (-1.04%)
After Hours
Last Updated: 00:00:05
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 NeuroBo Pharmaceuticals Inc NASDAQ:NRBO NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.05 -1.04 4.78 4.74 4.97 5.30 4.65 4.83 150,687 23:00:05   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -12.47M -2.5418 -1.86 23.16M
 Type  Size  Price  Time  Units 
 9 3 4.86 22:43:21 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore NRBO News
26/06/202414:06PRNUSNeuroBo Pharmaceuticals Doses First Patient in the MAD Part 2 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
25/06/202422:08PRNUSNeuroBo Pharmaceuticals Announces the Closing of up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
24/06/202413:01PRNUSNeuroBo Pharmaceuticals Announces up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
22/06/202413:01PRNUSNeuroBo Pharmaceuticals' DA-1726 Demonstrated Superiority in Weight Loss, Retention of Lean Body Mass, and Lipid-Lowering Effects Compared to Survodutide, in Pre-Clinical Models
08/06/202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
07/06/202421:06EDGAR2Form 8-K - Current report
22/05/202413:30EDGAR2Form 8-K - Current report
Period
Draw mode
Data Downloads for NRBO

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest NeuroBo Pharmaceuticals Inc Articles